Bristol-Myers Squibb

Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
CP WIre
Mon, 12/10/18 - 11:35 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
micro
Bristol-Myers Squibb and Vedanta Biosciences to Evaluate Opdivo and VE800 in Patients with Advanced or Metastatic Cancers
Mon, 12/10/18 - 11:34 pm
Bristol-Myers Squibb
Vedanta Biosciences
Opdivo
VE800
microbiome
CEO of Chapel Hill firm talks 2 new partnerships with big pharma
Bizjournals
Sat, 12/8/18 - 10:31 am
Target PharmaSolutions
Gilead Sciences
Bristol-Myers Squibb
hepatitis B
NASH
BMS' second small-cell trial flop endangers Opdivo lung cancer approval: analyst
Fierce Pharma
Tue, 11/27/18 - 11:39 pm
Bristol-Myers Squibb
Opdivo
Yervoy
extensive-stage small cell lung cancer
Bristol-Myers Drops After Lung-Cancer Drug Study Fails
TheStreet.com
Tue, 11/27/18 - 12:15 pm
Bristol-Myers Squibb
Opdivo
Yeroy
extensive-stage small cell lung cancer
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
Bristol-Myers Squibb laying off 69 employees in Florida in push to 'focus resources'
Fierce Pharma
Fri, 11/16/18 - 07:54 pm
Bristol-Myers Squibb
layoffs
Florida
How Bristol-Myers Squibb Company Fell $18.8 Billion in October
Motley Fool
Sun, 11/11/18 - 09:00 pm
Bristol-Myers Squibb
Opdivo
Bristol-Myers Squibb snags quick Empliciti combo nod in multiple myeloma
Fierce Pharma
Thu, 11/8/18 - 09:41 am
Bristol-Myers Squibb
AbbVie
Empliciti
FDA
Multiple Myeloma
Celgene
Pomalyst
Bristol-Myers lays off the last 63 staffers at ZymoGenetics, shutters Seattle operations
Endpoints
Wed, 11/7/18 - 10:09 am
Bristol-Myers Squibb
layoffs
ZymoGenetics
Pharma Giants Merck, Bristol Diverge On Earnings Beat As Sales Lag
Investors.com
Thu, 10/25/18 - 11:46 pm
Merck
Bristol-Myers Squibb
earnings
Bristol-Myers Squibb stock drops 6% after FDA delays approval deadline for cancer drug
Marketwatch
Mon, 10/22/18 - 12:21 pm
Bristol-Myers Squibb
clinical trials
Opdivo
Yervoy
FDA
Pfizer preps for BMS showdown with Bavencio kidney cancer combo data
Fierce Pharma
Sun, 10/21/18 - 11:28 pm
Pfizer
Bristol-Myers Squibb
kidney cancer
Bavencio
Up on Deck! Ten Q3 Biotech Earnings Reports to Watch Next Week
BioSpace
Sat, 10/20/18 - 11:16 pm
earnings
biotech
Biogen
Alexion Pharmaceuticals
Bristol-Myers Squibb
Celgene
Gilead Sciences
Merck
Biomarin
Galapagos
Seattle Genetics
Dr Reddy's
FDA, EMA delay review of Opdivo/Yervoy for first-line NSCLC
BioCentury
Sat, 10/20/18 - 11:13 pm
Bristol-Myers Squibb
Opdivo
FDA
EMA
Yervoy
non-small cell lung cancer
Real threat to Opdivo’s small-cell chances will come from elsewhere
EP Vantage
Tue, 10/16/18 - 09:42 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
FDA
Tecentriq
Roche
Stada and Mylan targeting Bristol-Myers Squibb’s Upsa (€1bn)
GoinPharma
Sun, 10/14/18 - 04:46 pm
Stada
OTC
Upsa
Bristol-Myers Squibb
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
CP Wire
Fri, 10/12/18 - 10:17 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
clinical trials
Bristol-Myers Squibb's Opdivo Misses Primary Endpoint in Ph III Study in Small Cell Lung Cancer
Fri, 10/12/18 - 09:23 am
Bristol-Myers Squibb
Opdivo
Small-Cell Lung Cancer
Bristol-Myers to invest in Compugen, collaborate in clinical trials
Yahoo/Reuters
Thu, 10/11/18 - 09:43 am
Bristol-Myers Squibb
CompuGen
clinical trials
solid tumors
COM701
Opdivo

Pages